Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Expert Opinion on Therapeutic Patents
|
August 5, 2009
The role of sulfamide derivatives in medicinal chemistry: a patent review (2006-2008)
Allen B Reitz, Garry R Smith, Michael H Parker
Current Topics in Medicinal Chemistry
|
November 26, 2009
Hit triage using efficiency indices after screening of compound libraries in drug discovery
Allen B Reitz, Garry R Smith, Brett A Tounge, et al.
Current Topics in Medicinal Chemistry
|
October 23, 2014
8-Hydroxyquinoline and hydroxamic acid inhibitors of botulinum neurotoxin BoNT/A
Tobin J Dickerson, Garry R Smith, Jeffrey C Pelletier, et al.
Journal of Molecular Neuroscience : MN
|
November 27, 2013
Small-molecule anticonvulsant agents with potent in vitro neuroprotection and favorable drug-like properties
Garry R Smith, Douglas E Brenneman, Yan Zhang, et al.
ACS Chemical Neuroscience
|
July 12, 2011
Enhancing the Pharmacokinetic Properties of Botulinum Neurotoxin Serotype A Protease Inhibitors Through Rational Design
Petr Capek, Yan Zhang, Deborah J Barlow, et al.
ARKIVOC : Free Online Journal of Organic Chemistry
|
June 7, 2011
Pseudomonas aeruginosa porphobilinogen synthase assembly state regulators: hit discovery and initial SAR studies
Allen B Reitz, Ursula D Ramirez, Linda Stith, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 28, 2014
Anilino-monoindolylmaleimides as potent and selective JAK3 inhibitors
Mark E McDonnell, Haiyan Bian, Jay Wrobel, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 1, 2012
Reexamining hydroxamate inhibitors of botulinum neurotoxin serotype A: extending towards the β-exosite
Garry R Smith, Dejan Caglič, Petr Capek, et al.
ACS Medicinal Chemistry Letters
|
July 24, 2018
Dipeptide Prodrugs of the Glutamate Modulator Riluzole
Jeffrey C Pelletier, Suzie Chen, Haiyan Bian, et al.
Drug and Alcohol Dependence
|
March 19, 2018
Chemokines and 'bath salts': CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in rats
Chicora F Oliver, Steven J Simmons, Sunil U Nayak, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Expert Opinion on Therapeutic Patents
|
August 5, 2009
The role of sulfamide derivatives in medicinal chemistry: a patent review (2006-2008)
Allen B Reitz, Garry R Smith, Michael H Parker
Current Topics in Medicinal Chemistry
|
November 26, 2009
Hit triage using efficiency indices after screening of compound libraries in drug discovery
Allen B Reitz, Garry R Smith, Brett A Tounge, et al.
Current Topics in Medicinal Chemistry
|
October 23, 2014
8-Hydroxyquinoline and hydroxamic acid inhibitors of botulinum neurotoxin BoNT/A
Tobin J Dickerson, Garry R Smith, Jeffrey C Pelletier, et al.
Journal of Molecular Neuroscience : MN
|
November 27, 2013
Small-molecule anticonvulsant agents with potent in vitro neuroprotection and favorable drug-like properties
Garry R Smith, Douglas E Brenneman, Yan Zhang, et al.
ACS Chemical Neuroscience
|
July 12, 2011
Enhancing the Pharmacokinetic Properties of Botulinum Neurotoxin Serotype A Protease Inhibitors Through Rational Design
Petr Capek, Yan Zhang, Deborah J Barlow, et al.
ARKIVOC : Free Online Journal of Organic Chemistry
|
June 7, 2011
Pseudomonas aeruginosa porphobilinogen synthase assembly state regulators: hit discovery and initial SAR studies
Allen B Reitz, Ursula D Ramirez, Linda Stith, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 28, 2014
Anilino-monoindolylmaleimides as potent and selective JAK3 inhibitors
Mark E McDonnell, Haiyan Bian, Jay Wrobel, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 1, 2012
Reexamining hydroxamate inhibitors of botulinum neurotoxin serotype A: extending towards the β-exosite
Garry R Smith, Dejan Caglič, Petr Capek, et al.
ACS Medicinal Chemistry Letters
|
July 24, 2018
Dipeptide Prodrugs of the Glutamate Modulator Riluzole
Jeffrey C Pelletier, Suzie Chen, Haiyan Bian, et al.
Drug and Alcohol Dependence
|
March 19, 2018
Chemokines and 'bath salts': CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in rats
Chicora F Oliver, Steven J Simmons, Sunil U Nayak, et al.
Page
of 3